What are the causes of erythema nodosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Erythema Nodosum

Erythema nodosum is most commonly caused by streptococcal infections, followed by sarcoidosis, inflammatory bowel disease, tuberculosis, and medications, though up to 32% of cases are idiopathic with no identifiable cause. 1, 2, 3

Clinical Presentation and Diagnosis

Erythema nodosum presents as:

  • Tender, erythematous subcutaneous nodules (1-5 cm in diameter)
  • Typically located symmetrically on the anterior tibial areas (shins)
  • Often accompanied by systemic symptoms including arthralgia and fatigue
  • More common in women than men 1

Diagnosis is primarily made on clinical grounds, with skin biopsy reserved for atypical cases 4.

Major Causes of Erythema Nodosum

1. Infections

  • Streptococcal infections: Most common identifiable cause, particularly streptococcal pharyngitis 2, 3
  • Tuberculosis: Particularly primary tuberculosis 3
  • Mycoplasma infections 3
  • Bartonella infections 3
  • Other bacterial infections

2. Inflammatory Conditions

  • Sarcoidosis: Second most common cause in adults 2, 3
  • Inflammatory bowel disease: Including Crohn's disease and ulcerative colitis 4, 3
  • Behçet's syndrome 1, 3

3. Medications

  • Oral contraceptives
  • Antibiotics
  • Other medications 2

4. Other Causes

  • Pregnancy 5
  • Malignancies: Can be a paraneoplastic manifestation 2, 6

5. Idiopathic

  • No identifiable cause in approximately 32% of cases 3

Diagnostic Approach

When evaluating a patient with erythema nodosum, the following investigations should be considered:

  1. Basic laboratory tests:

    • Complete blood count with differential
    • Erythrocyte sedimentation rate and/or C-reactive protein
    • Testing for streptococcal infection (throat culture, rapid antigen test, antistreptolysin-O titer) 1, 2
  2. Imaging:

    • Chest radiograph (to evaluate for sarcoidosis, tuberculosis) 1, 2
  3. Additional testing based on clinical suspicion:

    • Tuberculin skin test for suspected tuberculosis
    • Stool cultures for suspected inflammatory bowel disease
    • Specific serologies for suspected infections 1, 2

Treatment Considerations

Treatment should focus on the underlying cause:

  • Streptococcal infections should be treated with appropriate antibiotics 5
  • For inflammatory bowel disease-associated erythema nodosum, treatment of the underlying IBD is usually effective 4
  • Systemic corticosteroids may be required in severe cases 4, 1
  • For resistant cases or frequent relapses, immunomodulators such as azathioprine or TNF-α antagonists (infliximab, adalimumab) may be considered 4, 1
  • Supportive care including rest, elevation of affected limbs, and pain management with NSAIDs 1, 7

Prognosis

Erythema nodosum is typically self-limited, resolving without scarring within 3-6 weeks, though it may persist longer in some cases. Prognosis is generally good, especially when any underlying cause is identified and treated appropriately 1.

References

Guideline

Erythema Nodosum Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Erythema nodosum: a sign of systemic disease.

American family physician, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Erythema nodosum associated with streptococcal infection in pregnancy.

Infectious diseases in obstetrics and gynecology, 1995

Research

Erythema Nodosum: A Practical Approach and Diagnostic Algorithm.

American journal of clinical dermatology, 2021

Research

Erythema nodosum.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.